US2007140968A1PendingUtilityA1

Method for determining botulinum potency

Assignee: ALLERGAN INCPriority: Mar 14, 2002Filed: Oct 24, 2006Published: Jun 21, 2007
Est. expiryMar 14, 2022(expired)· nominal 20-yr term from priority
A61K 8/64G01N 33/5088A61Q 19/08A61K 8/99A61K 8/02A61K 2800/70A61K 49/0006
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Skin topographical methods for quantifying pharmacodynamic parameters of a paralytic effect of a Clostridial toxin, such as a botulinum toxin upon a muscle, such as a frontalis muscle. The methods are effective in determining the potency of a Clostridial toxin, and in comparing toxins. For example, wrinkle reduction effects caused by one or more neurotoxins may be monitored, and differences in effects correspond to differences of neurotoxins.

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled)  
     
     
         16 . A method for determining the potency of a botulinum neurotoxin, comprising the steps of: examining a muscle of an individual at a maximum voluntary contraction; administering a composition comprising a botulinum neurotoxin to the muscle; and examining the muscle after the muscle has been administered the botulinum neurotoxin without killing the individual to determine an effect of the botulinum neurotoxin on the muscle.  
     
     
         17 . The method of  claim 16 , further comprising repeating the steps for a plurality of individuals.  
     
     
         18 . The method of  claim 17 , further comprising analyzing the effect of the botulinum neurotoxin on the muscle as a function of amount of the botulinum neurotoxin in the composition for each individual administered the composition.  
     
     
         19 - 42 . (canceled)

Join the waitlist — get patent alerts

Track US2007140968A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.